Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Promising Oral Compounds for the Treatment of Multiple Sclerosis: A Glance into the Future.
Emerging oral agents for multiple sclerosis.
Leflunomide: mode of action in the treatment of rheumatoid arthritis.
A map of the human neocortex showing the estimated overall myelin content of the individual architectonic areas based on the studies of Adolf Hopf.
Sex differences in comorbidity at diagnosis of multiple sclerosis: A population-based study.
Dimethyl Fumarate Inhibits the Nuclear Factor kappaB Pathway in Breast Cancer Cells by Covalent Modification of p65.
[Reduction of spastic increased muscle tone in multiple sclerosis by the nonopioid analgesic flupirtine].
A Safety and Efficacy Extension Study of ONO-4641 in Patients With Relapsing-Remitting Multiple Sclerosis (DreaMS)
Alterations of the optic pathway between unilateral and bilateral optic nerve damage in multiple sclerosis as revealed by the combined use of advanced diffusion kurtosis imaging and visual evoked potentials.
Infectious mononucleosis at the United States Military Academy. A prospective study of a single class over four years.
Biogen Idec and AbbVie announce positive top-line results from Phase 3 study investigating daclizumab high-yield process in multiple sclerosis
Reversible cerebral vasoconstriction syndrome associated with interferon beta-1a use for multiple sclerosis.
Postpartum relapses increase the risk of disability progression in multiple sclerosis: the role of disease modifying drugs.
Natalizumab may reduce cognitive changes and brain atrophy rate in relapsing-remitting multiple sclerosis: a prospective, non-randomized pilot study.
Severe delayed heart failure in three multiple sclerosis patients previously treated with mitoxantrone.
Guillain-Barré Syndrome (42 Cases) Occurring During a Zika Virus Outbreak in French Polynesia.
Cost-utility of fingolimod compared with dimethyl fumarate in highly active relapsing-remitting multiple sclerosis (RRMS) in England.
Dimethyl fumarate (BG-12, Tecfidera) approved for use by the NHS in Scotland
Effects of fumaric acid esters on blood-brain barrier tight junction proteins.
Autoimmune AQP4 channelopathies and neuromyelitis optica spectrum disorders.
Intravenous mitoxantrone and cyclophosphamide as second-line therapy in multiple sclerosis: an open-label comparative study of efficacy and safety.
Mylan's ANDA for Three Times Per Week Generic Copaxone® 40 mg/mL Accepted for Filing by FDA
Dimethyl Fumarate Ameliorates Lewis Rat Experimental Autoimmune Neuritis and Mediates Axonal Protection.
Peripheral Bilateral Telangiectasiae in Multiple Sclerosis Patients Treated with Interferon B1a.
Interleukin-10 but not transforming growth factor-β1 gene expression is up-regulated by vitamin D treatment in multiple sclerosis patients.

Pages